SLC25A20 and Other metabolic disease: Previous studies had reported that mutations in SLC25A20 are closely associated with carnitine-acylcarnitine-translocase deficiency, resulting in a variety of metabolic diseases such as hypoglycemia, hepatic dysfunction, and muscle weakness6–8.